• Mianserin HCl: Optimizing 5-HT2 Antagonist Workflows in Rese

  2026-05-26

  Mianserin HCl stands out as a 5-HT2 receptor antagonist for both psychiatric disorder research and antipathogenic screening. Discover actionable experimental strategies, protocol enhancements, and troubleshooting guidance that leverage its unique pharmacology and inclusion complex chemistry.

• Optimizing Affinity Purification with the 3X (DYKDDDDK) Pept

  2026-05-25

  The 3X (DYKDDDDK) Peptide offers unmatched sensitivity and versatility for recombinant protein purification and detection, especially in workflows challenged by metal ion interference or low-abundance targets. This guide translates recent structural and mechanistic advances into actionable strategies, ensuring reproducible results across affinity purification, immunodetection, and structural biology assays.

• QX77: Molecular Chaperone Activator for Autophagy Pathway St

  2026-05-25

  QX77 is a molecular chaperone activator that upregulates LAMP2A and Rab11 to induce chaperone-mediated autophagy. It serves as a valuable tool for research into autophagy pathway modulation and stem cell biology, with clear protocol and storage parameters. The compound’s efficacy and limitations are benchmarked using recent mechanistic insights and authoritative product data.

• Praeruptorin A Mitigates Acute Colitis via STAT-1/-3 Modulat

  2026-05-24

  This study establishes Praeruptorin A, an angular pyranocoumarin compound, as a potent modulator of the STAT-1/-3 pathway in experimental ulcerative colitis. The findings highlight its ability to reduce inflammation and restore intestinal barrier integrity, supporting its potential as a mechanistically targeted anti-inflammatory agent.

• Antibody-Based Mapping of Pseudouridine in Cellular and Vira

  2026-05-23

  This study introduces PA-Ψ-seq, a novel antibody-based technique for mapping pseudouridine (Ψ) residues on cellular and viral RNAs. The findings clarify the roles of key pseudouridine synthases in mRNA modification and reveal unexpected independence of viral Ψ patterns from major host enzymes, with implications for understanding RNA modification in innate immunity and synthetic mRNA design.

• Lymphodepleting Chemotherapy Enhances Neoantigen T Cell Ther

  2026-05-22

  Sagie et al. reveal that lymphodepleting chemotherapy, by augmenting antigen presentation via immunoproteasome activation and HLA-I upregulation, synergistically improves the efficacy of neoantigen-targeted T cell therapies. These mechanistic insights highlight new avenues for optimizing adoptive cell therapy (ACT) in solid tumors with low neoantigen abundance.

• Host CK2α–VP2 Interaction Drives CIAV Replication and Pathog

  2026-05-22

  This study elucidates how chicken infectious anemia virus (CIAV) exploits host casein kinase 2 alpha (CK2α) via a direct interaction with viral VP2 at Ser182 and Asp183 to achieve efficient replication. The findings reveal that targeting CK2α can suppress CIAV proliferation, offering a mechanistic foundation for antiviral strategy development.

• Cytoskeleton-Dependent Autophagy Under Mechanical Stress: Ke

  2026-05-21

  The referenced study directly demonstrates that the induction of autophagy by mechanical stress is critically dependent on the cellular cytoskeleton, particularly microfilaments, with microtubules playing a supportive role. These findings refine our understanding of mechanotransduction in autophagy and suggest new experimental approaches for dissecting calcium signaling pathways under mechanical challenge.

• Catalpol Induces Osteoclast Apoptosis to Alleviate Osteoporo

  2026-05-21

  This study demonstrates that catalpol prevents estrogen deficiency-induced osteoporosis in ovariectomized rats by promoting osteoclast apoptosis through the Sirt6-ERα-FasL signaling axis. The findings provide mechanistic insight into catalpol’s therapeutic effects and offer a foundation for further exploration of apoptosis-inducing agents in bone disease models.

• Hoechst 33342: Applied Workflows for Nuclear Imaging & Cell

  2026-05-20

  Hoechst 33342, a bis-benzimidazole fluorescent dye, delivers precise nuclear visualization for live and fixed cells, enabling robust cell cycle analysis and high-content apoptosis assays. This article distills advanced workflows, expert troubleshooting, and translational insights—anchored by recent research on organelle transport—to help researchers maximize data quality and reproducibility.

• Belinostat (PXD101): Protocol Optimization for Epigenetic Ca

  2026-05-20

  Belinostat (PXD101) empowers researchers to achieve robust histone deacetylase inhibition and reproducible cell cycle arrest in both urothelial and prostate cancer models. This article delivers actionable protocol enhancements, troubleshooting strategies, and data-driven insights tailored to maximize the translational impact of Belinostat in advanced epigenetic cancer workflows.

• DAPI (hydrochloride): Quantitative DNA Analysis in Immunomet

  2026-05-19

  Discover how DAPI (hydrochloride), a DNA-specific fluorescent probe, revolutionizes quantitative DNA analysis in immunometabolic research. This article uniquely integrates metabolic modulation insights and advanced assay design for next-generation applications.

• MK-1775 (Wee1 Kinase Inhibitor): Precision Tools for Functio

  2026-05-19

  Explore the mechanistic depth of MK-1775, a potent Wee1 kinase inhibitor, and learn how its unique checkpoint abrogation properties advance functional analysis of cell cycle control and DNA damage responses in p53-deficient cancers. This article delivers experimental insight and protocol guidance beyond standard workflows.

• Catalpol’s Multi-Modal Anticancer Actions: Pathways and Pers

  2026-05-18

  This comprehensive review synthesizes preclinical evidence on catalpol, an iridoid glycoside, highlighting its mechanisms in suppressing cancer proliferation, metastasis, and inflammation. The paper underscores catalpol’s modulation of key molecular pathways, suggesting broad potential for cancer intervention and future therapeutic research.

• Dissecting Drug Response in Cancer: In Vitro Evaluation Adva

  2026-05-18

  Schwartz's dissertation delivers a critical re-examination of how in vitro methods assess anti-cancer drug efficacy, distinguishing between proliferative arrest and cell death in drug response metrics. This work refines experimental approaches for more precise interpretation of compound effects, informing translational cancer research and assay optimization.

803 records 19/54 page Previous Next First page 上5页 1617181920 下5页 Last page